SUPER GROUP SGHC LTD (SGHC)

GG00BMG42V42 - Common Stock

6.2  -0.07 (-1.12%)

After market: 6.2 0 (0%)

Fundamental Rating

5

Overall SGHC gets a fundamental rating of 5 out of 10. We evaluated SGHC against 133 industry peers in the Hotels, Restaurants & Leisure industry. SGHC has an excellent financial health rating, but there are some minor concerns on its profitability. SGHC has a decent growth rate and is not valued too expensively.



4

1. Profitability

1.1 Basic Checks

SGHC had positive earnings in the past year.
SGHC had a positive operating cash flow in the past year.
In multiple years SGHC reported negative net income over the last 5 years.
In the past 5 years SGHC always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of SGHC (-1.10%) is worse than 67.69% of its industry peers.
SGHC has a Return On Equity (-2.02%) which is in line with its industry peers.
SGHC has a Return On Invested Capital of 10.40%. This is in the better half of the industry: SGHC outperforms 72.31% of its industry peers.
SGHC had an Average Return On Invested Capital over the past 3 years of 17.17%. This is significantly above the industry average of 10.64%.
The 3 year average ROIC (17.17%) for SGHC is well above the current ROIC(10.40%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.1%
ROE -2.02%
ROIC 10.4%
ROA(3y)15.84%
ROA(5y)13.87%
ROE(3y)26.29%
ROE(5y)N/A
ROIC(3y)17.17%
ROIC(5y)N/A

1.3 Margins

SGHC has a worse Operating Margin (5.22%) than 61.54% of its industry peers.
SGHC's Operating Margin has declined in the last couple of years.
The Profit Margin and Gross Margin are not available for SGHC so they could not be analyzed.
Industry RankSector Rank
OM 5.22%
PM (TTM) N/A
GM N/A
OM growth 3Y-27.69%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

SGHC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, SGHC has about the same amount of shares outstanding.
Compared to 1 year ago, SGHC has a worse debt to assets ratio.

2.2 Solvency

SGHC has an Altman-Z score of 6.34. This indicates that SGHC is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SGHC (6.34) is better than 90.00% of its industry peers.
SGHC has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
SGHC has a better Debt to FCF ratio (0.37) than 93.08% of its industry peers.
SGHC has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
SGHC has a Debt to Equity ratio of 0.05. This is amongst the best in the industry. SGHC outperforms 85.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.37
Altman-Z 6.34
ROIC/WACC1.13
WACC9.22%

2.3 Liquidity

SGHC has a Current Ratio of 1.26. This is a normal value and indicates that SGHC is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.26, SGHC is in the better half of the industry, outperforming 63.85% of the companies in the same industry.
A Quick Ratio of 1.26 indicates that SGHC should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.26, SGHC is in the better half of the industry, outperforming 67.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26

5

3. Growth

3.1 Past

The earnings per share for SGHC have decreased strongly by -18.97% in the last year.
SGHC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.14%.
Measured over the past years, SGHC shows a quite strong growth in Revenue. The Revenue has been growing by 16.51% on average per year.
EPS 1Y (TTM)-18.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)11.14%
Revenue growth 3Y16.51%
Revenue growth 5YN/A
Sales Q2Q%12.88%

3.2 Future

Based on estimates for the next years, SGHC will show a very strong growth in Earnings Per Share. The EPS will grow by 58.76% on average per year.
SGHC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.36% yearly.
EPS Next Y49.08%
EPS Next 2Y83.68%
EPS Next 3Y58.76%
EPS Next 5YN/A
Revenue Next Year14.33%
Revenue Next 2Y11.87%
Revenue Next 3Y10.36%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 34.44, the valuation of SGHC can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of SGHC is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.48, SGHC is valued a bit more expensive.
A Price/Forward Earnings ratio of 13.73 indicates a correct valuation of SGHC.
Based on the Price/Forward Earnings ratio, SGHC is valued cheaply inside the industry as 83.08% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of SGHC to the average of the S&P500 Index (23.73), we can say SGHC is valued slightly cheaper.
Industry RankSector Rank
PE 34.44
Fwd PE 13.73

4.2 Price Multiples

SGHC's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. SGHC is more expensive than 63.85% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as SGHC.
Industry RankSector Rank
P/FCF 38.07
EV/EBITDA 17.85

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SGHC's earnings are expected to grow with 58.76% in the coming years.
PEG (NY)0.7
PEG (5Y)N/A
EPS Next 2Y83.68%
EPS Next 3Y58.76%

4

5. Dividend

5.1 Amount

SGHC has a Yearly Dividend Yield of 6.38%, which is a nice return.
Compared to an average industry Dividend Yield of 2.93, SGHC pays a better dividend. On top of this SGHC pays more dividend than 96.15% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, SGHC pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.38%

5.2 History

SGHC is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y83.68%
EPS Next 3Y58.76%

SUPER GROUP SGHC LTD

NYSE:SGHC (1/3/2025, 8:04:01 PM)

After market: 6.2 0 (0%)

6.2

-0.07 (-1.12%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)N/A N/A
Inst Owners7.5%
Inst Owner Change0%
Ins Owners5.77%
Ins Owner ChangeN/A
Market Cap3.11B
Analysts82
Price Target7.91 (27.58%)
Short Float %1.1%
Short Ratio2.64
Dividend
Industry RankSector Rank
Dividend Yield 6.38%
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)112.42%
Min EPS beat(2)-1.96%
Max EPS beat(2)226.8%
EPS beat(4)2
Avg EPS beat(4)94.06%
Min EPS beat(4)-100%
Max EPS beat(4)251.4%
EPS beat(8)3
Avg EPS beat(8)45.68%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.93%
Min Revenue beat(2)9.42%
Max Revenue beat(2)10.44%
Revenue beat(4)4
Avg Revenue beat(4)6.94%
Min Revenue beat(4)1.57%
Max Revenue beat(4)10.44%
Revenue beat(8)6
Avg Revenue beat(8)3.82%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)29.17%
PT rev (3m)45.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)5.56%
EPS NY rev (3m)-9.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)1.81%
Valuation
Industry RankSector Rank
PE 34.44
Fwd PE 13.73
P/S 2.1
P/FCF 38.07
P/OCF 22.72
P/B 5.8
P/tB 13.01
EV/EBITDA 17.85
EPS(TTM)0.18
EY2.9%
EPS(NY)0.45
Fwd EY7.29%
FCF(TTM)0.16
FCFY2.63%
OCF(TTM)0.27
OCFY4.4%
SpS2.95
BVpS1.07
TBVpS0.48
PEG (NY)0.7
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.1%
ROE -2.02%
ROCE 13.16%
ROIC 10.4%
ROICexc 18.07%
ROICexgc 149.85%
OM 5.22%
PM (TTM) N/A
GM N/A
FCFM 5.52%
ROA(3y)15.84%
ROA(5y)13.87%
ROE(3y)26.29%
ROE(5y)N/A
ROIC(3y)17.17%
ROIC(5y)N/A
ROICexc(3y)34.83%
ROICexc(5y)N/A
ROICexgc(3y)196.54%
ROICexgc(5y)N/A
ROCE(3y)21.74%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-27.69%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.37
Debt/EBITDA 0.15
Cap/Depr 65.16%
Cap/Sales 3.73%
Interest Coverage 40.67
Cash Conversion 84.51%
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z 6.34
F-Score4
WACC9.22%
ROIC/WACC1.13
Cap/Depr(3y)46.84%
Cap/Depr(5y)34.86%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y49.08%
EPS Next 2Y83.68%
EPS Next 3Y58.76%
EPS Next 5YN/A
Revenue 1Y (TTM)11.14%
Revenue growth 3Y16.51%
Revenue growth 5YN/A
Sales Q2Q%12.88%
Revenue Next Year14.33%
Revenue Next 2Y11.87%
Revenue Next 3Y10.36%
Revenue Next 5YN/A
EBIT growth 1Y-11.45%
EBIT growth 3Y-15.76%
EBIT growth 5YN/A
EBIT Next Year256.92%
EBIT Next 3Y71.91%
EBIT Next 5YN/A
FCF growth 1Y-43.03%
FCF growth 3Y-17.1%
FCF growth 5YN/A
OCF growth 1Y-20.35%
OCF growth 3Y-4.24%
OCF growth 5YN/A